banner add

FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.

from NYT > Health https://ift.tt/ekZtz7g
via IFTTT

No comments

UnitedHealth Group Reports Flat First-Quarter Earnings

One of the nation’s largest insurers, the company’s profits were higher than analysts’ expectations but still fell short of showing a signif...

Theme images by PLAINVIEW. Powered by Blogger.